中国中西医结合杂志2018，Vol.38Issue(8)：932-935,4.DOI:10.7661/j.cjim.20180512.011
清胰化积方化裁联合西药治疗232例胰腺癌术后患者回顾性研究
Retrospective Study of 232 Post-operative Patients with Pancreatic Cancer Treated by Modified Qingyi Huaji Formula Combined with Western Medicine
摘要
Abstract
Objective To observe Modified Qingyi Huayi Formula (QYHJF) combined with Western medicine for post-operative pancreatic cancer patients.Methods We performed a retrospective study of 232 post-operative pancreatic cancer patients treated by QYHJF from Jan.2013 to Dec.2014.The patients were assigned to taking QYHJF≥3-month group (127 cases) and＜3-month group (105 cases) according to the time of treatment.The clinical characteristics, treatment approaches and overall survival were analyzed by Kaplan-Meier method and Log-rank test.Results The results showed that overall 1-, 2-, 3-year survival rates were 52％, 24％ and 18％ respectively, and median survival was 15.43 months.The 1-, 2-, 3-year survival rates for QYHJF treatment≥3-month group patients were 76％, 41％ and 32％, with a median survival of 20.77 months, while those for＜3-month group were38％, 12％ and 2％, with a median survival of 9.69 months.Compared with ＜3-month group, patients in QYHJF treatment≥3-month group had a better survival (P=0.001) .Conclusion QYHJF treatment for more than 3 months could prolong the survival time of post-operative patients with pancreatic cancer.关键词
胰腺癌/清胰化积方/术后/生存率Key words
pancreatic cancer/Qingyi Huaji Formula/post-operation/survival rate引用本文复制引用
宋利斌,刘鲁明,陈颢,陈震,孟志强,花永强,高惠峰,王鹏..清胰化积方化裁联合西药治疗232例胰腺癌术后患者回顾性研究[J].中国中西医结合杂志,2018,38(8):932-935,4.基金项目
国家自然科学基金资助项目(No.81173461) （No.81173461）
第六批全国老中医药专家学术经验继承工作项目(No.2017125) （No.2017125）
